Deuterium modification of tyrosine kinase inhibitors contributes to reversing ferroptosis resistance through upregulation of aldehyde oxidase 1 in hepatocellular carcinoma.
酪氨酸激酶抑制剂的氘修饰可通过上调肝细胞癌中的醛氧化酶 1 来逆转铁死亡抵抗。
期刊:Acta Pharmaceutica Sinica B
影响因子:14.6
doi:10.1016/j.apsb.2025.12.007
Ma Yue, Yi Chenhe, Cai Ning, Tao Baorui, Geng Yan, Shao Weiqing, Sun Rongquan, Chen Zhenmei, Li Yitong, Zhang Bo, Wang Xiangyu, Lin Jing, Zhu Wenwei, Lu Lu, Zhang Wanguang, Chen Jinhong